maps bulletin - volume xiv - number 1 - summer 2004
< Return to Table of Contents
When the Ordinary Becomes Addictive: Conference Report - Mainstream psychologists in New York adopt the harm reduction model
by Valerie Mojeiko

The definitions of use and abuse, dependence and addiction can be blurry, whether debated by treatment providers or a user's concerned peers. Questioning the meaning of addiction as a diagnostic term was the purpose of a conference sponsored by the New York State Psychological Association (NYSPA) at New School University in Manhatten, April 23, 2004. "Going Too Far: When the Ordinary Becomes Addictive" drew students, clinicians, and researchers from New York and the surrounding New England areas to examine the question.

The harm reduction paradigm was not only accepted at this mainstream psychology conference, it actually seemed to be considered the ideal. Leading harm reduction psycho- therapist Andrew Tatarsky, PhD, was at the top of the speaker lineup, setting a tone for the rest of the day. He challenged the "drug war mentality" that blames society's drug problems on drugs, and outlined the harm reduction approach, which emphasizes the user's relationship with, motives for, and methods of drug use.

While addiction is a lesser problem in the psychedelic community than in some other communities of drug users, the issue of drug addiction influences the moral and legal classification of all drugs.

Stanton Peele, PhD, J.D., whose once radical ideas about substance abuse and addic- tion have now become the norm, challenged the audience with still more controversial insights about the relative ineffectiveness of substance abuse treatment compared to no treatment at all. Also on the recreational drug panel was social worker Sippio Michael Small, C.S.W., who offered a racial perspective on drug use with observations from his work with children of color. A mostly educated, white-collar, Caucasian audience re- mained transfixed as Small explained how it is illegal in his hometown of Harlem to pass around a brown-bagged bottle of liquor in the park, while a few blocks away fancy street cafes serve wine and beer on the sidewalk to people of a different socio-economic back- ground.

Psychiatric medications earned their own panel, classified separately from illegal drugs in the conference (just like in the federal government regulatory systems). Presi- dent of the NYSPA Division of Addictions Julie Barnes, PhD, presented several scenarios in which patients "tricked" their doctors into prescribing a medications for recreational or otherwise illicit reasons. Robert Forman, PhD, of the Treatment Research Institute, gave an illuminating lecture on the availability of drugs on the Internet. Addictions psychia- trist Mark Green, MD, explained how heroin use has been replaced by use of prescription opioids such as oxycodone among teenagers.

Other panels at the conference addressed addictive patterns of eating and sex. This further served to lessen the stigma on addicts and take the emphasis off of the objects of their addictive behaviors. The therapists themselves could all accept and relate to the pleasures of eating and sex, even though many of them may have been inexperienced with the pleasures of drug use.

Changing views on addiction reflect a step forward in our society's understanding of drugs. While addiction is a lesser problem in the psychedelic community than in some other communities of drug users, the issue of drug addiction influences the moral and legal classification of all drugs. At this conference, I saw mainstream psychologists embracing the harm reduction model-yet another sign that the prohibitionist paradigms are changing. As the harm reduction model switches the responsibility to the user, and not the substance used, psychologists and the rest of the public may re-evaluate psyche- delics and marijuana, noting the often beneficial ways these substances are used. By switching the control, and the blame, away from the drugs themselves-we come one step closer to changing outdated drug prohibitory laws.

 
 
< Return to Table of Contents: Summer 2004 Issue - "10 stamps and $250,000"
 
Spring 2010 Vol. 20, No. 1 Special Edition: Psychedelics, Death and Dying
Autumn 2009 Vol. 19, No. 3 MAPS Financial Report: Fiscal Year 2008-09
Summer 2009 Vol. 19, No. 2 MAPS Research Update 2009
Spring 2009 Vol. 19, No. 1 Special Edition: Psychedelics and Ecology
Winter 2008/09 Vol. 18, No. 3 MAPS 2008 Financial Report
Summer 2008 Vol. 18, No. 2 Phoenix Rising: A Review of MAPS Research
Spring 2008 Vol. 18, No. 1 Special Edition: Technology and Psychedelics
Winter 2007 Vol. 17, No. 3 MAPS 06-07 Fiscal Yearly Report
Autumn 2007 Vol. 17, No. 2 Special Edition: Psychedelics and Self-Discovery
Spring/Summer 2007 Vol. 17, No. 1 The Chrysalis Stage
Winter 2006-7 Vol. 16, No. 3 Low Maintenance/High Performance
Autumn 2006 Vol. 16, No. 2 Technologies of Healing
Spring 2006 Vol. 16, No. 1 MAPS' 20th Anniversary
Winter 2005 Vol. 15, No. 3 MAPS final year as a teenager
Summer 2005 Vol. 15, No. 2 Israel Conference: MDMA/PTSD Research
Spring 2005 Vol. 15, No. 1 Accelerating flow of work and time
Autumn 2004 Vol. 14, No. 2 Rites of Passage: Kids and Psychedelics
Summer 2004 Vol. 14, No. 1 10 stamps and $250,000
Winter 2003 Vol. 13, No. 2 Holy Fire
Spring 2003 Vol. 13, No. 1 60th Anniversary of the Discovery of LSD
Autumn 2002 Vol. 12, No. 3 Vision
Summer 2002 Vol. 12, No. 2 "From celebration to frustration, and back again."
Spring 2002 Vol. 12, No. 1 Sex, Spirit & Psychedelics 2002
Autumn 2001 Vol. 11, No. 2 "In the future, it will be called Despair."
Spring 2001 Vol. 11, No. 1 "A Tidal Wave of Ecstasy!"
Autumn 2000 Vol. 10, No. 3 Creativity 2000
Summer 2000 Vol. 10, No. 2 Endings and Beginnings
Spring 2000 Vol. 10, No. 1 Making History in Slow Motion
Winter 1999/00 Vol. 9, No. 4 To the Ends of the Earth for MDMA Research...
Autumn 1999 Vol. 9, No. 3 MAPS' long-standing efforts to conduct...
Summer 1999 Vol. 9, No. 2 MAPS has come full circle...
Spring 1999 Vol. 9, No. 1 Patience, persistence and passion
Winter 1998/99 Vol. 8, No. 4 One of special pleasures of directing MAPS...
Autumn 1998 Vol. 8, No. 3 The Ayahuasca Issue (with Hofmann interview)
Summer 1998 Vol. 8, No. 2 Emotionally Powerful Anecdotes...
Spring 1998 Vol. 8, No. 1 Death Has a Way of Focusing One's Attention
Autumn 1997 Vol. 7, No. 4 Celebration is in Order
Summer 1997 Vol. 7, No. 3 Time Horizons
Spring 1997 Vol. 7, No. 2 Synchronicity
Winter 1996/97 Vol. 7, No. 1 Learning to Crawl
Autumn 1996 Vol. 6, No. 4 An Invitation for Dialogue
Summer 1996 Vol. 6, No. 3 Budding Research
New Year 1996 Vol. 6, No. 2 Sending Down Roots
Autumn 1995 Vol. 6, No. 1 Baby Steps
Summer 1995 Vol. 5, No. 4 Opportunity Amidst Obstacles
Winter 1994/95 Vol. 5, No. 3 Clinical Trials and Tribulations
Autumn 1994 Vol. 5, No. 2 Building Towards Clinical Trials
Summer 1994 Vol. 5, No. 1 Politics and Protocols: In Search of a Balance
Spring 1994 Vol. 4, No. 4 Laying the Groundwork
Winter 1993/94 Vol. 4, No. 3 A Time of Tests
Summer 1993 Vol. 4, No. 2 So Close Yet So Far
Spring 1993 Vol. 4, No. 1 Remembrance and Renewal
Winter 1992/93 Vol. 3, No. 4 Forging New Alliances
Summer 1992 Vol. 3, No. 3 Building on Common Ground
Spring 1992 Vol. 3, No. 2 Small Steps, Gradual Progress, New Opportunities
Winter 1991/92 Vol. 3, No. 1 The Rekindling of a Thousand Points of Light
Summer 1991 Vol. 2, No. 2 MDMA protocol development with cancer patients
Winter 1990/91 Vol. 2, No. 1 MAPS' Swiss pharmacologically-assisted psychotherapy conference
Autumn 1990 Vol. 1, No. 3 What and Who is MAPS?
Summer 1989 Vol. 1, No. 2 Switzerland Leads the Way
Summer 1988 Vol. 1, No. 1 MDMA can become a legal medicine